世界の消化管間質腫瘍分子診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4242
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、消化管間質腫瘍分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・消化管間質腫瘍分子診断の市場動向
・企業の競争状況、市場シェア
・消化管間質腫瘍分子診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ）
・消化管間質腫瘍分子診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究所）
・消化管間質腫瘍分子診断の北米市場規模2016-2027（アメリカ、カナダ）
・消化管間質腫瘍分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・消化管間質腫瘍分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・消化管間質腫瘍分子診断の中南米市場規模2016-2027（メキシコ、ブラジル）
・消化管間質腫瘍分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Yin Feng Gene、KingMed、Geneis、Haplox、AmoyDX、Admera、GeneChem）
・結論

A method for diagnosing gastrointestinal Stromal Tumor

Market Analysis and Insights: Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market
The global Gastrointestinal Stromal Tumor Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gastrointestinal Stromal Tumor Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gastrointestinal Stromal Tumor Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gastrointestinal Stromal Tumor Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gastrointestinal Stromal Tumor Molecular Diagnostics market.

Global Gastrointestinal Stromal Tumor Molecular Diagnostics Scope and Market Size
Gastrointestinal Stromal Tumor Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Stromal Tumor Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip

Segment by Application
Clinical Diagnosis
Drug Screening
Research

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Yin Feng Gene
KingMed
Geneis
Haplox
AmoyDX
Admera
GeneChem

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Perspective (2016-2027)
2.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Growth Trends by Regions
2.2.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Industry Dynamic
2.3.1 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Trends
2.3.2 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers
2.3.3 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Challenges
2.3.4 Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Revenue
3.1.1 Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue
3.4 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in 2020
3.5 Gastrointestinal Stromal Tumor Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Stromal Tumor Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Gastrointestinal Stromal Tumor Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gastrointestinal Stromal Tumor Molecular Diagnostics Breakdown Data by Type
4.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Type (2022-2027)

5 Gastrointestinal Stromal Tumor Molecular Diagnostics Breakdown Data by Application
5.1 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2016-2027)
6.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
6.2.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
6.3.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
6.4.1 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
7.2.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
7.3.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
7.4.1 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
9.2.1 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
9.3.1 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
9.4.1 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Yin Feng Gene
11.1.1 Yin Feng Gene Company Details
11.1.2 Yin Feng Gene Business Overview
11.1.3 Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.1.4 Yin Feng Gene Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
11.1.5 Yin Feng Gene Recent Development
11.2 KingMed
11.2.1 KingMed Company Details
11.2.2 KingMed Business Overview
11.2.3 KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.2.4 KingMed Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
11.2.5 KingMed Recent Development
11.3 Geneis
11.3.1 Geneis Company Details
11.3.2 Geneis Business Overview
11.3.3 Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.3.4 Geneis Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
11.3.5 Geneis Recent Development
11.4 Haplox
11.4.1 Haplox Company Details
11.4.2 Haplox Business Overview
11.4.3 Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.4.4 Haplox Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
11.4.5 Haplox Recent Development
11.5 AmoyDX
11.5.1 AmoyDX Company Details
11.5.2 AmoyDX Business Overview
11.5.3 AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.5.4 AmoyDX Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
11.5.5 AmoyDX Recent Development
11.6 Admera
11.6.1 Admera Company Details
11.6.2 Admera Business Overview
11.6.3 Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.6.4 Admera Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
11.6.5 Admera Recent Development
11.7 GeneChem
11.7.1 GeneChem Company Details
11.7.2 GeneChem Business Overview
11.7.3 GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Introduction
11.7.4 GeneChem Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
11.7.5 GeneChem Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Regions (2022-2027)
Table 12. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Trends
Table 13. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Drivers
Table 14. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Challenges
Table 15. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Restraints
Table 16. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics as of 2020)
Table 19. Ranking of Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Gastrointestinal Stromal Tumor Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Gastrointestinal Stromal Tumor Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Yin Feng Gene Company Details
Table 64. Yin Feng Gene Business Overview
Table 65. Yin Feng Gene Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 66. Yin Feng Gene Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Yin Feng Gene Recent Development
Table 68. KingMed Company Details
Table 69. KingMed Business Overview
Table 70. KingMed Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 71. KingMed Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 72. KingMed Recent Development
Table 73. Geneis Company Details
Table 74. Geneis Business Overview
Table 75. Geneis Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 76. Geneis Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Geneis Recent Development
Table 78. Haplox Company Details
Table 79. Haplox Business Overview
Table 80. Haplox Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 81. Haplox Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 82. Haplox Recent Development
Table 83. AmoyDX Company Details
Table 84. AmoyDX Business Overview
Table 85. AmoyDX Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 86. AmoyDX Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 87. AmoyDX Recent Development
Table 88. Admera Company Details
Table 89. Admera Business Overview
Table 90. Admera Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 91. Admera Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Admera Recent Development
Table 93. GeneChem Company Details
Table 94. GeneChem Business Overview
Table 95. GeneChem Gastrointestinal Stromal Tumor Molecular Diagnostics Product
Table 96. GeneChem Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 97. GeneChem Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Gastrointestinal Stromal Tumor Molecular Diagnostics Report Years Considered
Figure 11. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Players in 2020
Figure 16. Global Top Gastrointestinal Stromal Tumor Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal Stromal Tumor Molecular Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue in 2020
Figure 18. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Gastrointestinal Stromal Tumor Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Region (2016-2027)
Figure 40. China Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Gastrointestinal Stromal Tumor Molecular Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Yin Feng Gene Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
Figure 60. KingMed Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
Figure 61. Geneis Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
Figure 62. Haplox Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
Figure 63. AmoyDX Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
Figure 64. Admera Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
Figure 65. GeneChem Revenue Growth Rate in Gastrointestinal Stromal Tumor Molecular Diagnostics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

以下、関連資料のご紹介

世界の皮膚がん分子診断市場規模・現状・予測（2021年-2027年）

Global Skin Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4867 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、皮膚がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の喉頭がん分子診断市場規模・現状・予測（2021年-2027年）

Global Laryngeal Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4412 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、喉頭がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界のリンパ腫分子診断市場規模・現状・予測（2021年-2027年）

Global Lymphoma Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4449 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、リンパ腫分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界のがん腫瘍プロファイリング市場規模・現状・予測（2021年-2027年）

Global Cancer Tumor Profiling Market Size, Status and Forecast 2021-2027
QFJ1-3960 2021年6月 120Pages
QYResearch社発行の本調査レポートでは、がん腫瘍プロファイリングの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（次世代シーケンシング（NGS）、ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、インサイツハイブリダイゼーション（ISH...

世界の白血病分子診断市場規模・現状・予測（2021年-2027年）

Global Leukemia Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4423 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、白血病分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の黒色腫分子診断市場規模・現状・予測（2021年-2027年）

Global Melanoma Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4488 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、黒色腫分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の前がん病変分子診断市場規模・現状・予測（2021年-2027年）

Global Precancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4742 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、前がん病変分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米...

世界の膀胱がん分子病理学診断市場規模・現状・予測（2021年-2027年）

Global Bladder Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-3914 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、膀胱がん分子病理学診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究所）、主要地域別市場規模...

世界の肝がん分子診断市場規模・現状・予測（2021年-2027年）

Global Liver Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4434 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、肝がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の膵臓がん分子診断市場規模・現状・予測（2021年-2027年）

Global Pancreatic Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4649 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、膵臓がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界のリンパ腫分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing lymphoma Market Analysis and Insights: Global Lymphoma Molecular Diagnostics Market The global Lymphoma Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-st…
世界の皮膚がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing skin cancer Market Analysis and Insights: Global Skin Cancer Molecular Diagnostics Market The global Skin Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…
世界の黒色腫分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing melanoma Market Analysis and Insights: Global Melanoma Molecular Diagnostics Market The global Melanoma Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-st…
世界の前がん病変分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing precancer Market Analysis and Insights: Global Precancer Molecular Diagnostics Market The global Precancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry…
世界の膵臓がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing pancreatic cancer Market Analysis and Insights: Global Pancreatic Cancer Molecular Diagnostics Market The global Pancreatic Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during …